Results
eNauka >
Rezultati >
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
| Naziv: | Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies | Autori: | Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Young, James; Dimkovic, Nada B; Reusch, Michael | Godina: | 2023 | Publikacija: | ADVANCES IN THERAPY | ISSN: | 0741-238X Advances in Therapy Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 40 br. 4 str. 1546-1559 | DOI: | 10.1007/s12325-023-02433-0 | WoS-ID: | 000928891900001 | Scopus-ID: | 2-s2.0-85147586736 | URI: | https://enauka.gov.rs/handle/123456789/826144 | Projekat: | Astellas Pharma, Inc. (DOLOMITES) FibroGen, Inc. AstraZeneca [NCT02021318] [NCT02273726] [NCT02052310] [NCT02174731] |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21M21 - Vodeći međunarodni časopis kategorije M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.